LSV Asset Management

LSV Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

LSV Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-165	Closed	-$11K	–	1126
2016 Q1	$11K	Hold	165	–	–	﹤0.01%	1019
2015 Q4	$11K	Hold	165	–	–	﹤0.01%	1001
2015 Q3	$13K	Hold	165	–	–	﹤0.01%	957
2015 Q2	$12K	Hold	165	–	–	﹤0.01%	940
2015 Q1	$14K	Hold	165	–	–	﹤0.01%	899
2014 Q4	$15K	Hold	165	–	–	﹤0.01%	917
2014 Q3	$16K	Hold	165	–	–	﹤0.01%	892
2014 Q2	$21K	Hold	165	–	–	﹤0.01%	858
2014 Q1	$28K	Hold	165	–	–	﹤0.01%	842
2013 Q4	$24K	Hold	165	–	–	﹤0.01%	869
2013 Q3	$27K	Hold	165	–	–	﹤0.01%	958
2013 Q2	$19K	Buy	+165	New	+$18.9K	﹤0.01%	867

Other funds holding VBIV

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Twin Focus Capital Partners Boston, Massachusetts $870M AUM 27.72% 1-Year Est. Return

Sigma Investment Management Portland, Oregon $125M AUM 4.75% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return